Details of the Drug

General Information of Drug (ID: DMVKFYS)

Drug Name
EC0225
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Cross-matching ID
PubChem CID
71306400
TTD ID
D01BPP

References

1 ClinicalTrials.gov (NCT00441870) Study of EC0225 for the Treatment of Refractory or Metastatic Tumors. U.S. National Institutes of Health.